| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $31.9M | +34.9% |
| R&D Expense | $81.4M | +12.9% |
| SG&A Expense | $18.8M | +2.8% |
| Operating Income | -$68.3M | +41.5% |
| Income Tax | $0 | — |
| Net Income | -$67.7M | +42.0% |
| EPS (Basic) | -$2.04 | +43.6% |
| EPS (Diluted) | -$2.04 | +43.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $51.6M | +15.5% |
| Short-term Investments | $1.5M | -98.3% |
| Current Assets | $54.7M | -60.3% |
| Total Assets | $73.7M | -52.6% |
| Current Liabilities | $52.4M | -11.3% |
| Total Liabilities | $68.3M | -29.8% |
| Stockholders' Equity | $5.4M | -90.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$89.2M | +27.0% |
| Capital Expenditures | $347K | +247.0% |
| Investing Cash Flow | $89.7M | +161.2% |
| Financing Cash Flow | $6.4M | -94.3% |
| Free Cash Flow | -$89.5M | +26.8% |